Navigation Links
OpenQ Secures Investment from Leading Mid-Atlantic Venture Firm

Grotech Ventures Backs Innovative Information, Research and Technology Platform for Life Sciences Marketing, R&D and Medical Affairs

Charlottesville, VA, San Diego, CA, New York, NY and Paris, France (PRWeb) -- OpenQ, the industry leader in innovative tools for information and research for life sciences marketing, compliance, R&D and medical affairs announces that it has secured an equity investment from Grotech Ventures. The new capital will fuel an expansion of openQ into new markets and new research areas.

"We are thrilled to receive an investment and strategic guidance from a fund like Grotech, who has a track record of enabling technology, information and services for life sciences companies to grow and meet their full potential," stated Jim Zuffoletti, openQ President. "My co-founder, Otavio Freire, and I look forward to our continued partnership in securing openQ's position as a leader in its sector providing technology, information and research to life sciences companies around the world."

"Grotech is pleased to begin a collaboration with openQ to help the company extend their current leadership position as an innovator in life sciences technology and information. We are impressed with openQ's rapid growth and successful track record serving the largest pharmaceutical and the smallest biotechs with creative solutions to help ensure compliance, speed time to approval, and accelerate adoption," added Chuck Cullen, General Partner at Grotech.

The openQ Platfom

The openQ platform includes breakthrough tools and research to identify trends, organizations and key individuals who impact adoption and scientific dialogue while ensuring compliance. The company's easy to use technology provides instant access to vital market information updated in real time. The openQ platform includes the following on-demand information and software tools:

  • openIdentify - the only real time KOL identification solution for marketing, medical affairs and R&D, backed by over 500 million records of dynamically updated information
  • openPresenter - the only slide management solution to ensure complete online and offline speaker compliance
  • openProfile - the leading information solution to support competitive intelligence and medical and marketing program planning
  • openKOL - for marketing teams to successfully engage KOLs
  • openMSL - the leading solution for managing field medical organizations
  • openSpeaker - for Speaker selection and speaker bureau management
  • openIIT - for IIT compliance, submission and approval workflow

About openQ

In its sixth year of rapid growth, openQ has offices throughout the United States, Asia, and Europe and a growing client list that spans the globe. The continued interest of life science companies in openQ's products has led them to expand their client base fourfold since 2006. The company serves eight of the top ten pharmaceutical companies and three of the top five medical device companies. For more information, visit

About Grotech Ventures

Founded in 1984, Grotech Ventures is a leading early investor in high-potential technology companies. Grotech seeks investments in communications and IT infrastructure, software and services, and Internet and digital media. The firm focuses on the Mid-Atlantic and Southeast regions and other select geographies. Grotech continues to invest and add value throughout the growth of its portfolio companies. The firm has a strong combination of financial backing, industry relationships, and deep domain and operational expertise to accelerate growth. With over $1 billion under management in its seven funds, Grotech supports early-stage companies through investments starting at $500,000. For further information, visit


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. OpenQ Posts a 200% Revenue Growth in the First Half of 2009
2. OpenQ is Awarded Prestigious Life Sciences Industry Award
3. Cappella Inc. Secures $17.3 Million Series C Investment
4. SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Germany & Austria
5. Sinobiopharma Secures Rights to Seven Key Patents
6. Aerovance Secures $38 Million in Equity Financing
7. VIA Pharmaceuticals Secures Financing Up to $10.0 Million
8. Pearl Therapeutics Secures $8 Million in Debt Financing
9. Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets
10. Sopherion Therapeutics Secures $55 Million in Series C Funding
11. Northwest Biotherapeutics Secures $700,000 Equity Financing
Post Your Comments:
(Date:11/25/2015)... November 26, 2015 ... Market 2016 - 2020 report analyzes that automating ... and quality in long-term samples, minimizing manual errors, ... Automation minimizes manual errors such as mislabeling or ... Further, it plays a vital role in blood ...
(Date:11/25/2015)... -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today ... Neurocrine Biosciences, will be presenting at the 27th Annual ... . .   Listeners ... prior to the presentation to download or install any ... available on the website approximately one hour after the ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... were featured on AngelList early in their initial angel funding process. Now, they ... for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" ... reported financial results for the quarter ended September ... in Canadian dollars and presented under International Financial ... States ," said Andrew Rae , ... regarding iCo-008 are not only value enriching for ...
Breaking Biology Technology:
(Date:11/18/2015)... 18, 2015  As new scientific discoveries deepen our ... other healthcare providers face challenges in better using that ... In addition, as more children continue to survive pediatric ... and old age. John M. Maris, M.D ... of Philadelphia (CHOP) . --> John ...
(Date:11/17/2015)... 17, 2015  Vigilant Solutions announces today that Mr. ... of Directors. --> --> ... from the partnership at TPG Capital, one of the ... $140 Billion in revenue.  He founded and led TPG,s ... TPG companies, from 1997 to 2013.  In his first ...
(Date:11/12/2015)... 2015  Arxspan has entered into an agreement ... for use of its ArxLab cloud-based suite of ... partnership will support the institute,s efforts to electronically ... information internally and with external collaborators. The ArxLab ... the Institute,s electronic laboratory notebook, compound and assay ...
Breaking Biology News(10 mins):